Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity
M Theisen, D Dodoo, A Toure-Balde, S Soe, G Corradin, K K Koram, J A Kurtzhals, L Hviid, T Theander, B Akanmori, M Ndiaye, P Druilhe
Dive into the research topics of 'Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity'. Together they form a unique fingerprint.